Kepivance and mucosal inflammation 
Kepivance and mucosal inflammation Patient Reports February 13, 2012
Kepivance Side Effects Report #5126747-X
Kepivance side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 02, 2006. Male patient, 62 years of age, was diagnosed with stomatitis and was treated with Kepivance. After drug was administered, patient experienced the following side effects: condition aggravated, dysgeusia, dyspnoea, macroglossia, mucosal inflammation, neutropenia, oedema peripheral, oral pain, osteonecrosis
. Kepivance dosage: unknown. During the same period patient was treated with LISINOPRIL, PANTOPRAZOLE, TAMSULOSIN, FENTANYL, OXYCONTIN, MELPHALAN. Patient recovered.Kepivance Side Effects Report #5072272-4
Kepivance side effect was reported by a Pharmacist from CANADA on July 25, 2006. Male patient, weighting 180.8 lb, was diagnosed with stomatitis and was treated with Kepivance. After drug was administered, patient experienced the following side effects: blister, erythema, mucosal inflammation, neuropathy, neutrophil count increased, oedema peripheral, oral viral infection, petechiae, rash maculo-papular. Kepivance dosage: unknown. During the same period patient was treated with NEUPOGEN, ETOPOSIDE, MELPHALAN. Patient was hospitalized. Patient recovered.
Kepivance Side Effects Report #5078848-2
Kepivance side effect was reported by a Physician from CANADA on July 25, 2006. Male patient, weighting 180.8 lb, was diagnosed with stomatitis and was treated with Kepivance. After drug was administered, patient experienced the following side effects: blister, erythema, mucosal inflammation, neuropathy, neutrophil count increased, oedema peripheral, oral viral infection, petechiae, rash maculo-papular. Kepivance dosage: unknown. During the same period patient was treated with NEUPOGEN, ETOPOSIDE, MELPHALAN, TOBRAMYCIN, CEFAZOLIN, PIPERACILLIN. Patient was hospitalized. Patient recovered.
Kepivance Side Effects Report #4864208-3
Kepivance side effect was reported by a Physician from GERMANY on Dec 12, 2005. Male patient, 44 years of age, was diagnosed with prophylaxis and was treated with Kepivance. After drug was administered, patient experienced the following side effects: blister, complications of transplant surgery, erythema, hypocalcaemia, infection
, mucosal inflammation, skin exfoliation, transplant failure. Kepivance dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died on 12/14/2005.Kepivance Side Effects Report #4897703-1
Kepivance side effect was reported by a Physician from GERMANY on Dec 12, 2005. Male patient, weighting 176.4 lb, was diagnosed with prophylaxis and was treated with Kepivance. After drug was administered, patient experienced the following side effects: blister, erythema, hypocalcaemia, infection
, mucosal inflammation, skin exfoliation, transplant failure. Kepivance dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, PIPERACILLIN, CEFTAZIDIME, BUTAZOLIDIN, CIPROBAY, PENICILLIN, CLONT, MESNA. Patient was hospitalized. Patient died on 12/14/2005.Kepivance Side Effects Report #5372587-6
Kepivance side effect was reported by a Physician from BELGIUM on June 12, 2007. Male patient, 46 years of age, weighting 200.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: mucosal haemorrhage, mucosal inflammation, swollen tongue. Kepivance dosage: unknown. Patient recovered.
Kepivance Side Effects Report #4949408-6
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: fluid retention, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion, weight increased. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #4949409-8
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 149.9 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: capillary leak syndrome, cardiac disorder, circulatory collapse, hypotension, lung infiltration, mucosal inflammation, pneumonia
, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, PIPERACILLIN, METRONIDAZOLE, ZOVIRAX, FLUCONAZOLE, SANDIMMUNE. Patient was hospitalized. Patient died on 02/13/2006.Kepivance Side Effects Report #4949410-4
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: capillary leak syndrome, fluid retention, lung infiltration, mucosal inflammation, pneumonia
, respiratory failure, weight increased. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE. Patient was hospitalized. Patient died on 01/29/2006.Kepivance Side Effects Report #4955293-9
Kepivance side effect was reported by a Physician from GERMANY on Mar 16, 2006. Male patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: clostridial infection, diarrhoea, mucosal inflammation, nausea
, therapeutic response decreased. Kepivance dosage: unknown. During the same period patient was treated with CYCLOSPORINE, METHOTREXATE, THYMOGLOBULIN, ACYCLOVIR, COTRIM, MERONEM, DIFLUCAN, VANCOMYCIN. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #4966049-5
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #4966067-7
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 149.9 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: capillary leak syndrome, circulatory collapse, hepatocellular damage, hypotension, jugular vein thrombosis, lung infiltration, mucosal inflammation, pancreatitis, pneumonia
. Kepivance dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, PIPERACILLIN, METRONIDAZOLE, ZOVIRAX, FLUCONAZOLE, SANDIMMUNE, CYCLOPHOSPHAMIDE, CEFTAZIDIME. Patient was hospitalized. Patient died on 02/13/2006.Kepivance Side Effects Report #4974997-5
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, capillary leak syndrome, clostridial infection, clostridium colitis, fluid retention, lung infiltration, lung injury, mucosal inflammation, pneumonia
. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CASPOFUNGIN. Patient was hospitalized. Patient died on 01/29/2006.Kepivance Side Effects Report #4993491-9
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 149.9 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: capillary leak syndrome, circulatory collapse, hypotension, lung infiltration, mucosal inflammation, pneumonia
, respiratory failure, staphylococcal sepsis. Kepivance dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, PIPERACILLIN, METRONIDAZOLE, ZOVIRAX, FLUCONAZOLE, SANDIMMUNE, CYCLOPHOSPHAMIDE, CEFTAZIDIME. Patient was hospitalized. Patient died on 02/13/2006.Kepivance Side Effects Report #4993498-1
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #4993499-3
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, capillary leak syndrome, clostridial infection, fluid retention, lung infiltration, lung injury, mucosal inflammation, pneumonia
, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CASPOFUNGIN. Patient was hospitalized. Patient died on 01/29/2006.Kepivance Side Effects Report #4994851-2
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #4994856-1
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, capillary leak syndrome, clostridial infection, fluid retention, lung infiltration, lung injury, mucosal inflammation, pneumonia
, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CASPOFUNGIN. Patient was hospitalized. Patient died on 01/29/2006.Kepivance Side Effects Report #4994862-7
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 149.9 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: capillary leak syndrome, circulatory collapse, hypotension, lung infiltration, mucosal inflammation, pneumonia
, respiratory failure, staphylococcal sepsis. Kepivance dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, PIPERACILLIN, METRONIDAZOLE, ZOVIRAX, FLUCONAZOLE, SANDIMMUNE, CYCLOPHOSPHAMIDE, CEFTAZIDIME. Patient was hospitalized. Patient died on 02/13/2006.Kepivance Side Effects Report #5019950-0
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #5019953-6
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 149.9 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: capillary leak syndrome, circulatory collapse, hypotension, lung infiltration, mucosal inflammation, pneumonia
, respiratory failure, staphylococcal sepsis. Kepivance dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, PIPERACILLIN, METRONIDAZOLE, ZOVIRAX, FLUCONAZOLE, SANDIMMUNE, CYCLOPHOSPHAMIDE, CEFTAZIDIME. Patient was hospitalized. Patient died on 02/13/2006.Kepivance Side Effects Report #5019954-8
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, capillary leak syndrome, clostridial infection, fluid retention, lung infiltration, lung injury, mucosal inflammation, pneumonia
, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CASPOFUNGIN. Patient was hospitalized. Patient died on 01/29/2006.Kepivance Side Effects Report #5351207-0
Kepivance side effect was reported by a Physician from BELGIUM on May 29, 2007. Male patient, 46 years of age, weighting 200.6 lb, was treated with Kepivance. After drug was administered, patient experienced the following side effects: mucosal inflammation, swollen tongue. Kepivance dosage: unknown. Patient recovered.